![]() |
|
|

Departament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona, Barcelona, Spain;
* APC Inc., Ankeny, IA 50021; and
APC Europe, S.A., Granollers, Spain
3To whom correspondence should be addressed. E-mail: mmoreto{at}ub.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: Staphylococcus aureus enterotoxin B intestinal inflammation glucose transport spray-dried porcine plasma immunoglobulin concentrate
Farm animals at weaning are exposed to many stresses (e.g., changing from a liquid to a solid diet) and frequently suffer infections, mainly caused by enterotoxigenic pathogens. Enteric infections may cause intestinal inflammation, villous atrophy, maldigestion, and malabsorption, which contribute to the high rates of mortality (1,2). Rats and mice can also develop intestinal inflammation at weaning, showing increased plasma cytokine concentrations (3) and increased numbers of T-helper secreting lymphocytes (4). In humans, dietary nutrient deficiencies (5) and acute bacterial infections also induce local immunoinflammatory reactions that may impair the absorptive and barrier functions of the intestine (6). Furthermore, infants may be sensitized to dietary antigens even during breast-feeding, which can also alter the barrier function of the gut (7) and eventually have a negative effect on growth.
In weanling pigs, dietary supplementation with spray-dried animal plasma (SDAP)4 has shown beneficial effects in growth and performance (8,9). In calves infected with Cryptosporidium parvum, bovine serum concentrate reduced fecal losses and returned villous surface area to normal values (10). SDAP has been proposed as an alternative to antimicrobial medication (11,12). In humans, studies to assess the acceptability and safety of SDAP supplementation show that it may increase the fractional absorption of dietary lipid and of total energy in malnourished children (13). We have recently studied a rat model of mild intestinal inflammation to investigate the effects of dietary supplements on the pathophysiology of bacterial enterotoxins. With this model we demonstrated that dietary SDAP can modulate the immune response of gut-associated lymphoid tissue and prevent Staphylococcus aureus enterotoxin B (SEB)-induced intestinal water secretion (14).
The gastrointestinal tract, particularly the small intestine and its mucosal epithelium, is capable of rapid functional and morphological adaptations in response to evolutionary, genetic, and ontogenetic development and demands (15) as well as to environmental and nutritional challenges (16). Intestinal inflammation represents a pathological situation that can alter gastrointestinal function and morphology.
During intestinal inflammation, the barrier function of the epithelium is altered, and the absorption of nutrients may be impaired. For example, in rabbits with chronic ileal inflammation, both the affinity of apical sodium glucose transporter 1 (SGLT1) for D-glucose (D-Glc) and the activity of basolateral Na+/K+-ATPase are reduced (17). In C. parvuminfected rats there is also impairment of Na+-glucose cotransport, although the effect may be ascribed to a concomitant reduction in villous height (18). Absorption of amino acids is also impaired in a rabbit model (19) and in a rat model (20) of intestinal inflammation. In the present study, we investigated the effects of dietary supplementation with SDAP or immunoglobulin concentrates on the intestinal transport of D-Glc and amino acids in rats challenged with SEB.
| METHODS |
|---|
|
|
|---|
At d 21 after birth, rats were weaned, randomly distributed into 4 groups, and fed the experimental diets until d 35. Rats in the control group were fed a control diet (without plasma proteins but containing an isonitrogenous amount of dried milk protein); rats in the SEB group were fed the control diet and were treated with SEB; rats in the SEB-SDAP group were fed a diet supplemented with 80 g SDAP/kg diet and were treated with SEB; and rats in the SEB-IC group were fed a diet supplemented with 22.7 g porcine immunoglobulin concentrate (IC)/kg diet and were treated with SEB. The SDAP and IC supplements were obtained from the same batch of fresh porcine blood (APC Europe) and the full composition of the diets was identical to that used in a previous study (14).
All protocols used in this study were approved by the ethical committees of the Universitat de Barcelona and of the regional government (Departament dAgricultura, Ramadaria i Pesca, Generalitat de Catalunya) for the use and handling of experimental animals.
Brush border membrane vesicle preparation.
Brush border membrane vesicles (BBMVs) were prepared using the MgCl2 precipitation method (21). For each BBMV preparation, the small intestine (except the proximal 5 cm) of 2 rats was used. After successive centrifugations, the final pellet was resuspended in a medium containing 300 mmol/L mannitol, 0.1 mmol/L MgSO4, 0.41 µmol/L LiN3, and 20 mmol/L Hepes/Tris (pH 7.4), with a protein concentration of 1520 g/L. The purity of BBMV preparations was assessed from the enrichment factor of marker enzymes. Sucrase (
-D-glucohydrolase, EC 3.2.1.48) activity, the marker of brush border membrane, was determined according to Garriga et al. (22). The activity of the ouabain-sensitive Na+/K+-ATPase (EC 3.6.1.3) was routinely assayed as a marker of the basolateral membrane as previously described (22). The overall recovery of enzymatic activities was calculated as the sum of recoveries of all fractions. In addition, membrane orientation was studied according to Garriga et al. (22).
Transport and kinetic studies. The uptakes of D-Glc and L-amino acids were measured at 25°C by a rapid filtration technique, as described elsewhere (22). For the studies of the effect of specific glucose transporter type 2 (GLUT2) inhibitors on initial rates of D-Glc transport, the BBMVs were incubated in a medium in which the NaCl was replaced by KCl to prevent transport across SGLT1.
The kinetic analysis of D-Glc uptake was carried out by nonlinear regression analysis of total D-Glc fluxes from 6 independent experiments, using the Biosoft EnzFitter program (Biosoft). Because the errors associated with experimental fluxes were roughly proportional to their values, the data were proportionally weighted.
The initial rates of L-leucine, L-methionine, and L-lysine uptake were measured by incubating BBMVs for 3 s in a medium containing an aliquot of radiolabeled L-amino acid (L-[3H]-leucine, L-[14C]-methionine, or L-[14C]-lysine, New England Nuclear Research Products; final activity: 1.12.0 mCi/L), 100 mmol/L mannitol, 100 mmol/L NaCl, 20 mmol/L Hepes/Tris (pH 7.4), 0.1 mmol/L MgSO4, and 0.41 µmol/L LiN3. Initial rates were determined at initial concentrations of the substrates that were either low (0.1 mmol/L) or relatively high (10 mmol/L for L-leucine and L-lysine and 1 mmol/L for L-methionine, because of its lower water solubility).
Phlorizin binding. The specific steady-state phlorizin binding to SGLT1 was assayed to determine the correlation between D-Glc transport rate and the number of SGLT1 transporters present in the BBMVs, using the method described by Garriga et al. (22). Each determination was carried out in triplicate using 4 different BBMV preparations. The specific phlorizin binding was expressed as pmol bound phlorizin/mg protein at a phlorizin concentration of 50 µmol/L (B50).
Western blot analysis of SGLT1. Measurements of SGLT1 protein abundance in BBMVs of rat small intestine were performed using Western-blot analysis, as previously described (23). Blots were incubated with a rabbit polyclonal antibody raised against the synthetic peptide corresponding to amino acids 564575 of the deduced amino acid sequence of rabbit intestinal SGLT1 at a 1:5000 dilution for 16 h at 4°C. In simultaneous experiments, nitrocellulose membranes were incubated with the same antibody previously preadsorbed with the antigenic peptide (1 g/L). Hybridization bands were quantified by scanning densitometry.
Determination of myeloperoxidase activity. Myeloperoxidase (MPO) activity was measured as an indicator of neutrophil infiltration in mucosal samples from the jejunum and was determined as described previously (14). One unit of MPO activity (UMPO) is defined as the amount of enzyme that degrades 1 µmol H2O2/min at 25°C.
Immunohistochemistry. Jejunum fragments (0.5 cm) were fixed with IHC Zinc Fixative® (Becton Dickinson) at 20°C for 24 h, then embedded in OCT compound medium (Miles). Cryostat sections (10 µm; 30°C) were prepared, transferred onto glass slides, and dried overnight at room temperature. Sections were postfixed with acetone at 20°C for 10 min, then permeabilized with Triton® X-100 (Sigma) 0.1% and blocked with 1% bovine serum albumin (v:v; Sigma) at room temperature for 30 min. Sections were then incubated with the same rabbit polyclonal anti-SGLT1 used for Western blot analysis (1:500 dilution in PBS) in a humidified chamber overnight at 4°C. Sections were washed with PBS and incubated with secondary antibody, Alexa 548 conjugated goat anti-rabbit antibody (Molecular Probes; 1:300 dilution in PBS), for 1 h at room temperature. Sections were rinsed in PBS and mounted in Mowiol®-488 (Calbiochem).
Image acquisition and processing. Sections (4 per rat) were scanned with a confocal scanning laser microscope (CLSM SPII, Leica) in a blinded protocol. The captured images were analyzed using the ImageJ program (24) to quantify the fluorescence from the antibody. The fluorescence intensity was quantified and expressed as the mean gray level per pixel of the stained area.
Statistical analyses. Results were expressed as means ± SEM. The effects of SEB were tested by comparing the SEB and control groups by ANOVA using SPSS-10.0 software (SPSS). To analyze the effects of dietary supplementation, the SEB-SDAP and SEB-IC groups were compared with the SEB group by ANOVA followed by Scheffés post-hoc test. Differences were considered significant at P < 0.05.
RESULTS
Mucosal enzyme activities. SEB treatment stimulated mucosal MPO activity compared to the control group (SEB group, 3.1 ± 0.2 UMPO/g mucosa; control group, 2.2 ± 0.2 UMPO/g mucosa; P < 0.05). Dietary supplementation with SDAP or IC did not affect the SEB-induced MPO activity (SEB-SDAP group, 2.9 ± 0.2 UMPO/g mucosa; SEB-IC group, 3.2 ± 0.4 UMPO/g mucosa). Neither SEB treatment nor dietary supplements affected the activities of the mucosal marker enzymes, sucrase and Na+/K+-ATPase (Table 1).
|
Transport of D-Glu across BBMVs. SEB treatment reduced the maximal transport rate (Vmax) across the apical SGLT1 by 20% (P < 0.05) and increased passive permeability (Kd) 3-fold (P < 0.05) (Table 2). The Michaelis constant (Km) did not differ between the SEB group and the other groups (Table 2). The SDAP-supplemented diet increased the D-Glc Vmax by 10% compared to the SEB group, without affecting the passive component (Table 2). The IC-supplemented diet did not affect the D-Glc kinetic constants.
|
Specific phlorizin binding measurements. There was a linear correlation between D-Glc Vmax and specific binding of 50 µmol/L phlorizin (Fig. 1), indicating that the changes in D-Glc Vmax were due to changes in the density of SGLT1 transporters in the membrane. This linear correlation between D-Glc Vmax and B50 is defined by the equation y = 3.63x 107.5 (r = 0.9468; P < 0.05). The slope of the line is the turnover number for the phlorizin binding site; that is, the number of cycles SGLT1/s. The value obtained in the present experiments (3.63 cycles/s) is in the range of values previously reported for chicken (22) and rabbit intestine (25).
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
downregulates Na+-coupled D-Glc transport in T84 cells (28) and that TNF
inhibits D-fructose uptake in rabbit intestine (29) supports the view that cytokines produced during inflammatory processes may be involved in the control of nutrient transporter expression.
Our results from immune staining SGLT1 showed that the protein is present in absorptive epithelial cells along the crypt-villus axis, with higher expression in the upper villous region than in the mid and basal regions, confirming the results of Ferraris et al. (30). The findings that the integrity of the mucosa and the size of the villi were not affected by SEB administration support the view that the effects of SEB on mucosal morphology are small, if any. Therefore, the changes in D-Glc transport kinetics observed in rats challenged with SEB are due to specific effects on the function of SGLT1. The kinetic analysis of D-Glc transport also showed that SEB increased D-Glc Kd
3-fold. This observation raised the possibility that SEB affected the passive flux of D-Glc across a low affinity GLUT-type facilitated mechanism located in the apical membrane (31). However, the use of specific inhibitors demonstrated that our brush border vesicles lacked any facilitated D-Glc transport and confirmed that the rise in the transmembrane D-Glc flux during the enterotoxin-induced mucosal inflammation was the result of increased D-Glc simple diffusion.
SEB administration had no observable effect on amino acid uptake rates in the present study. This differs from the results of Topouchian et al. (20), who reported a marked decrease in leucine and glutamate fluxes across the mucosa of rats infected with C. parvum, an effect that was attributed to a decrease in the Na+ electrochemical gradient (18). We observed no effect of SEB administration on Na+/K+-ATPase in the mucosal homogenates either, indicating that the absorption of nutrients whose uptake depends on the maintenance of Na+ and electrical gradients across the membrane will not be affected.
In rats challenged with SEB, SDAP increased SGLT1 maximal transport capacity. No changes occurred in the SEB-IC group. This effect of SDAP was confirmed by Western and immunohistochemistry analyses of the mucosa. SDAP, a complex mixture of serum proteins used as food additives in farm animal production, improves growth and performance in pigs (8) and has been suggested as an alternative to antimicrobial medication (11). Although the mechanism of action of SDAP is still controversial, there is evidence that it prevents pathogen infectivity by improving immunocompetence and reducing bacterial adhesion to the mucosa (32). Recently, Bosi et al. (9) showed that SDAP can also reduce proinflammatory cytokine expression in the gut of early-weaned piglets challenged with enterotoxigenic Escherichia coli K88, and Pérez-Bosque et al. (14) have observed that SDAP brings SEB-induced cytotoxic populations back to values close to those in healthy rats. These findings agree with the lower intravillous lamina propria cell density observed by Jiang et al. (33) and are consistent with the view that SDAP can limit the production of cytokines by modulating the immune response.
The nutritional consequences of increased passive permeability and reduced mediated uptake on total D-Glc absorption are difficult to predict. After a meal, the luminal concentration of D-Glc is expected to be high, and in this condition absorption of D-Glc in vivo by apical transporters and by simple diffusion will also be high. The effects of SEB on passive permeability would enhance D-Glc absorption by the nonmediated transcellular pathway, fully compensating for the small reduction in SGLT1 Vmax. We calculated that in control rats, at a luminal D-Glc concentration of 50 mmol/L, 25% of total uptake would take place by the mediated mechanism and 75% by simple diffusion, whereas in SEB rats, these figures would be 6 and 94%, respectively. At low luminal D-Glc concentrations, however, the contribution of enhanced Kd would be low, while the mediated pathway would contribute substantially. We estimated that at a luminal D-Glc concentration of 0.2 mmol/L, a level typically found during interdigestive periods (34), SDAP would increase the intestinal capacity to absorb D-Glc by 89%. This small but significant effect may contribute to the increase in growth and performance observed in farm animals fed SDAP supplements (8,9).
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Supported by the programs PROFIT (FIT-0100002003-164) and Eureka Euroagri (E!2452) and by grant 2001SGR0142 (Generalitat de Catalunya, Spain). ![]()
4 Abbreviations used: BBMV, brush border membrane vesicle; D-Glc, D-glucose; GLUT2, glucose transporter type 2; IC, immunoglobulin concentrate; i.p., intraperitoneal; Kd, diffusion constant; Km, Michaelis constant; MPO, myeloperoxidase; SDAP, spray-dried animal plasma; SEB, Staphylococcus aureus enterotoxin B; SEB-IC, Staphylococcus aureus enterotoxin B plus immunoglobulin concentrate; SEB-SDAP, Staphylococcus aureus enterotoxin B plus spray-dried animal plasma; SGLT1, sodium glucose transporter 1; UMPO, unit of myeloperoxidase activity; Vmax, maximal transport rate. ![]()
Manuscript received 8 February 2005. Initial review completed 4 March 2005. Revision accepted 27 April 2005.
| LITERATURE CITED |
|---|
|
|
|---|
1. Van Beers-Schreurs H.M.G., Nabuurs M., Vellenga L., Kalsbeek-van der Valk H. J., Wensing T., Breukink H. Weaning and the weanling diet influence the villous height and crypt depth in the small intestine of pigs and alter the concentrations of short-chain fatty acids in the large intestine and blood. J. Nutr. 1998;128:947-953.
2. Van Dijk A. J., Niewold T. A., Nabuurs M. J., Van Hees J., De Bot P., Stockhofe-Zurwieden N., Ubbink-Blanksma M., Beynen A. C. Small intestinal morphology and disaccharidase activities in early-weaned piglets fed a diet containing spray-dried porcine plasma. J. Vet. Med. A. Physiol. Pathol. Clin. Med. 2002;49:81-86.[Medline]
3. Mengheri E., Ciapponi L., Vignolini E., Nobili F. Cytokine gene expression in intestine of rat during the postnatal developmental period: increased IL-1 expression at weaning. Life Sci. 1996;59:1227-1236.[Medline]
4. Vázquez E., Gil A., García-Olivares E., Rueda R. Weaning induces an increase in the number of specific cytokine-secreting intestinal lymphocytes in mice. Cytokine. 2000;12:1267-1270.[Medline]
5. Calder P. C., Kew S. The immune system: a target for functional foods?. Br. J. Nutr. 2002;88:S165-S176.
6. Salminen S., Bouley C., Boutron-Ruault M. C., Cummings J. H., Franck A., Gibson G. R., Isolauri E., Moreau M. C., Roberfroid M., Rowland I. Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998;80:S147-S171.
7. Arvola T., Moilanen E., Vuento R., Isolauri E. Weaning to hypoallergenic formula improves gut barrier function in breast-fed infants with atopic eczema. J. Pediatr. Gastroenterol. 2004;38:92-96.[Medline]
8. Coffey R. D., Cromwell G. L. The impact of environment and antimicrobial agents on the growth responses of early-weaned pigs to spray-dried porcine plasma. J. Anim. Sci. 1995;73:2532-2539.[Abstract]
9. Bosi P., Casini L., Finamore A., Cremokolini C., Merialdi G., Trevisi P., Nobili F., Mengheri E. Spray-dried plasma improves growth performance and reduces inflammatory status of weaned pigs challenged with enterotoxigenic Escherichia coli K88. J. Anim. Sci. 2004;82:1764-1772.
10. Hunt E., Fu Q., Armstrong M. U., Rennix D. K., Webster D. W., Galanko J. A., Chen W., Weaver E. M., Argenzio R. A., Rhoads J. M. Oral bovine serum concentrate improves cryptosporidial enteritis in calves. Pediatr. Res. 2002;51:370-376.[Medline]
11. Torrallardona D., Conde M. R., Esteve-Garcia E., Brufau J. Use of spray-dried animal plasma as an alternative to antimicrobial medication in weanling pigs. Anim. Feed Sci. Technol. 2002;99:119-129.
12. Torrallardona D., Conde M. R., Badiola I., Polo J., Brufau J. Effect of fishmeal replacement with spray-dried animal plasma and colistin on intestinal structure, intestinal microbiology, and performance of weanling pigs challenged with Escherichia coli K99. J. Anim. Sci. 2003;81:1220-1226.
13. Lembcke J. L., Peerson J. M., Brown K. H. Acceptability, safety, and digestibility of spray-dried bovine serum added to diets of recovering malnourished children. J. Pediatr. Gastroenterol. Nutr. 1997;25:381-384.[Medline]
14. Pérez-Bosque A., Pelegrí C., Vicario M., Castell M., Russell L., Campbell J. M., Quigley J. D., 3rd, Polo J., Amat C., Moretó M. Dietary plasma protein affects the immune response of weaned rats challenged with S. aureus superantigen B. J. Nutr. 2004;134:2667-2672.
15. Ferraris R. P. Dietary and developmental regulation of intestinal sugar transport. Biochem. J. 2001;360:265-376.[Medline]
16. Levin R. J. Digestion and absorption of carbohydratesfrom molecules and membranes to humans. Am. J. Clin. Nutr. 1994;59(3 suppl.):690S-698S.
17. Sundaram U., Coon S., Wisel S., West A. B. Corticosteroids reverse the inhibition of Na+-glucose cotransport in the chronically inflamed rabbit ileum. Am. J. Physiol. 1999;276:G211-G218.
18. Capet C., Kapel N., Huneau J. F., Magne D., Laikuen R., Tricottet V., Benhamou Y., Tome D., Gobert J. G. Cryptosporidium parvum infection in suckling rats: impairment of mucosal permeability and Na+-glucose cotransport. Exp. Parasitol. 1999;91:119-125.[Medline]
19. Sundaram U., Wisel S., Fromkes J. J. Unique mechanism of inhibition of Na+-amino acid cotransport during chronic ileal inflammation. Am. J. Physiol. 1998;275:G483-G489.
20. Topouchian A., Huneau J. F., Barbot L., Rome S., Gobert J. G., Tomé D., Kapel N. Evidence for the absence of an intestinal adaptive mechanism to compensate for C. parvum-induced amino acid malabsorption in suckling rats. Parasitol. Res. 2003;91:197-203.[Medline]
21. Vázquez C. M., Rovira N., Ruiz-Gutiérrez V., Planas J. M. Developmental changes in glucose transport, lipid composition, and fluidity of jejunal BBM. Am. J. Physiol. 1997;273:R1086-R1093.
22. Garriga C., Moretó M., Planas J. M. Hexose transport in the apical and basolateral membranes of enterocytes in chickens adapted to high and low NaCl intakes. J. Physiol. 1999;514(1):189-199.
23. Garriga C., Rovira N., Planas J. M., Moretó M. Expression of Na+-D-glucose cotransporter in brush-border membrane of the chicken intestine. Am. J. Physiol. 1999;276:R627-R631.
24. Rasband W. Expression of Na+-D-glucose cotransporter in brush-border membrane of the chicken intestine. ImageJ. 19972005 U.S. National Institutes of Health Bethesda, MD. http://rsb.info.nih.gov/ij/ [accessed April 2005].
25. Wright E. M., Peerce B. E. Sodium-dependent conformational changes in the intestinal glucose carrier. Ann. N.Y. Acad. Sci. 1985;456:108-114.[Medline]
26. Sundaram U., Wisel S., Rajendran V., West A. B. Mechanism of inhibition of Na+-glucose cotransport in the chronically inflamed rabbit ileum. Am. J. Physiol. 1997;273:G913-G919.[Medline]
27. Sekikawa S., Kawai Y., Fujiwara A., Takeda K., Tegoshi T., Uchikawa R., Yamada M., Arizono N. Alterations in hexose, amino acid and peptide transporter expression in intestinal epithelial cells during Nippostrongylus brasiliensis infection in the rat. Int. J. Parasitol. 2003;33:1419-1426.[Medline]
28. Yoo D., Lo W., Goodman S., Ali W., Semrad C., Field M. Interferon-gamma downregulates ion transport in murine small intestine cultured in vitro. Am. J. Physiol. 2000;279:G1323-G1332.
29. García-Herrera J., Navarro M. A., Marca N. C., de la Osada J., Rodríguez-Yoldi M. J. The effect of tumor necrosis factor-
on D-fructose intestinal transport in rabbits. Cytokine. 2004;25:21-30.[Medline]
30. Ferraris R. P., Villenas S. A., Hirayama B. A., Diamond J. M. Effect of diet on glucose transporter site density along the intestinal crypt-villus axis. Am. J. Physiol. 1992;262:G1060-G1068.
31. Kellett G. L. The facilitated component of intestinal glucose absorption. J. Physiol. 2001;531(3):585-595.
32. Van Dijk A. J., Everts H., Nabuurs M. J., Margry R. J., Beynen A. C. Growth performance of weanling pigs fed spray-dried animal plasma: a review. Livest. Prod. Sci. 2001;68:263-274.[Medline]
33. Jiang R., Chang X., Stoll B., Fan M. Z., Arthington J., Weaver E., Campbell J., Burrin D. G. Dietary plasma protein reduces small intestinal growth and lamina propria cell density in early weaned pigs. J. Nutr. 2000;130:21-26.
34. Ferraris R. P., Yasharpour S., Lloyd K. C., Mirzayan R., Diamond J. M. Luminal glucose concentrations in the gut under normal conditions. Am. J. Physiol. 1990;259:G822-G837.
This article has been cited by other articles:
![]() |
M. Moreto and A. Perez-Bosque Dietary plasma proteins, the intestinal immune system, and the barrier functions of the intestinal mucosa J Anim Sci, April 1, 2009; 87(14_suppl): E92 - E100. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Balan, K.-S. Han, S. M. Rutherfurd, H. Singh, and P. J. Moughan Orally Administered Ovine Serum Immunoglobulins Influence Growth Performance, Organ Weights, and Gut Morphology in Growing Rats J. Nutr., February 1, 2009; 139(2): 244 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez-Bosque, L. Miro, J. Polo, L. Russell, J. Campbell, E. Weaver, J. Crenshaw, and M. Moreto Dietary Plasma Proteins Modulate the Immune Response of Diffuse Gut-Associated Lymphoid Tissue in Rats Challenged with Staphylococcus aureus Enterotoxin B J. Nutr., March 1, 2008; 138(3): 533 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Crenshaw, R. D. Boyd, J. M. Campbell, L. E. Russell, R. L. Moser, and M. E. Wilson Lactation feed disappearance and weaning to estrus interval for sows fed spray-dried plasma J Anim Sci, December 1, 2007; 85(12): 3442 - 3453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez-Bosque, C. Amat, J. Polo, J. M. Campbell, J. Crenshaw, L. Russell, and M. Moreto Spray-Dried Animal Plasma Prevents the Effects of Staphylococcus aureus Enterotoxin B on Intestinal Barrier Function in Weaned Rats J. Nutr., November 1, 2006; 136(11): 2838 - 2843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mate, A. Barfull, A. M. Hermosa, L. Gomez-Amores, C. M. Vazquez, and J. M. Planas Regulation of sodium-glucose cotransporter SGLT1 in the intestine of hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R760 - R767. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garriga, R. R. Hunter, C. Amat, J. M. Planas, M. A. Mitchell, and M. Moreto Heat stress increases apical glucose transport in the chicken jejunum Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R195 - R201. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||